Evidence map›Paper›PMID 40756773›Full record

Observational studyTransboundary and emerging diseases2025

Sporadic Human Infections With

Yuting Ren, Yale Jiang, Zhoufu Xiang, Qi Cheng, Kehan Chen, Jianchun Ma, Jianwei Dai, Weihao Zhang, Wei Hou, Qiang Liu and 1 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Human infection by an unclassifiedNew microbes and new infections · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuting RenState Key Laboratory of Virology and Biosafety, Institute of Medical Virology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China.
Yale JiangState Key Laboratory of Virology and Biosafety, Institute of Medical Virology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China.
Zhoufu XiangState Key Laboratory of Virology and Biosafety, Institute of Medical Virology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China.
Qi ChengState Key Laboratory of Virology and Biosafety, Institute of Medical Virology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China.
Kehan ChenState Key Laboratory of Virology and Biosafety, Institute of Medical Virology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China.
Jianchun MaState Key Laboratory of Virology and Biosafety, Institute of Medical Virology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China.
Jianwei DaiState Key Laboratory of Virology and Biosafety, Institute of Medical Virology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China.
Weihao ZhangState Key Laboratory of Virology and Biosafety, Institute of Medical Virology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China.
Wei HouState Key Laboratory of Virology and Biosafety, Institute of Medical Virology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, Hubei, China.ORCID https://orcid.org/0000-0003-1439-455X
Qiang LiuDepartment of Infectious Diseases, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People's Hospital, Yichang, Hubei, China.ORCID https://orcid.org/0000-0002-9719-2023
Liangjun ChenDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.ORCID https://orcid.org/0000-0002-9529-9126

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japanese spotted fever (JSF) is an easily neglected infectious disease, where misdiagnosis and delayed treatment significantly contribute to poor prognoses in affected patients. Our prospective observational study (2021-2023) systematically characterized 56 JSF cases in Yichang through tripartite analysis encompassing epidemiological distributions, clinical phenotyping, and phylogenetic relationship analysis of

Indexed as

RickettsiaRickettsia InfectionsAdultAgedChinaFemaleHumansMaleMiddle AgedPhylogenyProspective Studiesclinical featuresepidemiological characteristicsJapanese spotted fever (JSF)Rickettsia japonicaspotted fever group rickettsiosis

Identifiers

PMID40756773
PMCPMC12316499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.